WuXi PharmaTech To Seek U.S. FDA Approval For New Covance-Partnered Global Testing Site

BEIJING - China's leading contract research organization, WuXi PharmaTech, is set to seek American regulatory approval for a new preclinical testing facility it is building near Shanghai to expand its global reach, according to a senior WuXi executive